{{Rsnum
|rsid=17622208
|Gene=SLC22A5
|Chromosome=5
|position=132381358
|Orientation=plus
|GMAF=0.2447
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=SLC22A5
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 19.5 | 54.0 | 26.5
| HCB | 0.0 | 0.0 | 100.0
| JPT | 0.0 | 2.3 | 97.7
| YRI | 2.7 | 17.7 | 79.6
| ASW | 0.0 | 43.9 | 56.1
| CHB | 0.0 | 0.0 | 100.0
| CHD | 0.0 | 2.8 | 97.2
| GIH | 1.0 | 21.8 | 77.2
| LWK | 1.8 | 26.4 | 71.8
| MEX | 6.9 | 44.8 | 48.3
| MKK | 12.2 | 41.7 | 46.2
| TSI | 18.6 | 49.0 | 32.4
| HapMapRevision=28
}}

Also known as IBD5-IGR2230, the G>A mutation is associated with an increased risk of [[Crohn's Disease]]. {{PMID|18521914|OA=1
}}

{{PMID|18650832|OA=1
}} MAST3: a novel IBD risk factor that modulates TLR4 signaling.

{{PMID Auto
|PMID=24415875
|Title=Susceptibility to ulcerative colitis in Hungarian patients determined by gene-gene interactions
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}